Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Methyltransferase complex subunit METTL3 maintains genome stability of erythroid cells via MTHFD1-mediated nucleotide biosynthesis
Linlin Zhang, Huizhi Zhao, Shihui Wang, Xueting Wu, Donghao Liu, Hengchao Zhang, Qianqian Yang, Ying Cheng, Xiuyun Wu, Jiangwei Zhao, Shijie Zhang, Huan Zhang, Haojian Zhang, Qiaozhen Kang, Lixiang Chen, Xiuli An, Xiaoli Qu
Linlin Zhang, Huizhi Zhao, Shihui Wang, Xueting Wu, Donghao Liu, Hengchao Zhang, Qianqian Yang, Ying Cheng, Xiuyun Wu, Jiangwei Zhao, Shijie Zhang, Huan Zhang, Haojian Zhang, Qiaozhen Kang, Lixiang Chen, Xiuli An, Xiaoli Qu
View: Text | PDF
Research Article Cell biology Hematology

Methyltransferase complex subunit METTL3 maintains genome stability of erythroid cells via MTHFD1-mediated nucleotide biosynthesis

  • Text
  • PDF
Abstract

N6-methyladenosine (m6A) is a prevalent modification of mammalian mRNA. Increasing evidence has documented diverse roles of m6A in normal cell physiology and diseases. However, its functional role in erythropoiesis remains poorly understood. In this study, we found that deletion of Mettl3 using the EpoR-Cre mouse led to microcytic/hypochromic anemia due to defective erythropoiesis along with impaired hemoglobin biosynthesis. Mechanically, Mettl3 deficiency disrupted nucleotide biosynthesis, which induced DNA damage, leading to apoptosis of colony-forming unit–erythroid cells and cell-cycle arrest of erythroblasts. Integrated m6A-seq and RNA-seq analysis along with biochemical studies identified Mthfd1, a key enzyme involved in nucleotide biosynthesis, as a Mettl3 direct target gene. Furthermore, deletion of Mettl3 led to decreased expression of Mthfd1, accompanied by a shortage of nucleotides deoxythymidine monophosphate and inosine monophosphate, in erythroid cells. Additionally, inhibition of METTL3 in human erythroid cells led to similar phenotypic and molecular changes, indicating a conserved role of METTL3 in human and murine erythropoiesis. Our findings have identified an METTL3-m6A-MTHFD1 axis that plays a critical role in erythropoiesis by maintaining genome stability of erythroid cells via regulation of nucleotide biosynthesis. These findings provide important insights into the regulatory mechanisms of erythropoiesis and may have implications for underlying the mechanisms of anemias.

Authors

Linlin Zhang, Huizhi Zhao, Shihui Wang, Xueting Wu, Donghao Liu, Hengchao Zhang, Qianqian Yang, Ying Cheng, Xiuyun Wu, Jiangwei Zhao, Shijie Zhang, Huan Zhang, Haojian Zhang, Qiaozhen Kang, Lixiang Chen, Xiuli An, Xiaoli Qu

×

Figure 7

MTHFD1 deficiency in human erythroid cells phenocopied METTL3 inhibition defects.

Options: View larger image (or click on image) Download as PowerPoint

MTHFD1 deficiency in human erythroid cells phenocopied METTL3 inhibitio...
(A) Schematic of lentiviral MTHFD1-shRNA transduction and erythroid differentiation induction (n = 3/group). (B) qRT-PCR analysis of MTHFD1 knockdown efficiency at mRNA level in shRNA-luciferase, 2 groups of shRNA-MTHFD1 transduced cells (labeled shRNA-MTHFD1#1, and shRNA-MTHFD1#5 in the figure) (n = 3/group). (C) Western blot analysis of MTHFD1 knockdown efficiency and corresponding quantification at the protein level (n = 3/group). (D) Colony-forming ability of luciferase-control and MTHFD1-knockdown cells at day 6. Scale bar: 100 μm. (E) Growth curves of luciferase-control and MTHFD1-knockdown cells (n = 3/group). (F) Flow cytometric analysis of apoptosis by 7AAD/annexin V staining at days 7, 9, and 11 (n = 3/group). (G) Western blot analysis of γ-H2AX and corresponding quantification in luciferase-control and MTHFD1-knockdown cells at day 7 (n = 3/group). (H) The proportion of EdU+ cells was quantified by flow cytometry in luciferase-control and MTHFD1-knockdown cells on day 7 and quantification of MFI in EdU+ cells (n = 3/group). Data are presented as the mean ± SD. Two-way ANOVA with Tukey’s post hoc test was used to calculate statistical significance among multiple groups. **P < 0.01, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts